Table 1.

High expression of Annexin-A2 (ANXA2) in biopsies as an indicator of the survival rate

Tumor type	N	High ANXA2 expression (%)	p value	Results	Reference
Epithelial ovarian cancer	119	65/119 (54.62%)	<  0.001	Poor survival rate	[20]
Nasopharyngeal carcinoma	48	32/48 (66.67%)	0.025	Poor survival rate	[8]
Urothelial carcinoma	232	123/232 (53.02%)	0.012	Poor survival rate	[21]
Hepatocellular carcinoma	84	62/84 (73.81%)	0.005	Poor survival rate	[22]
Serous ovarian cancer	109	63/109 (57.79%)	0.044	Poor survival rate	[23]

Method: immunohistochemistry; N, total number of patients